EquitySectoral/ ThematicDirect · Growth
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option
Nippon India · Scheme 118759
₹642.89▼ 0.13%NAV · 2026-08-05
Strong FundScore
AUM
—
Expense ratio
—
3Y CAGR
19.1%
Risk level
High
Min SIP
—
Benchmark
Nifty 500 TRI
NAV Growth
Loading NAV history…
Historical returns
| Period | Return |
|---|---|
| 1 Month | +1.43% |
| 3 Months | +9.60% |
| 6 Months | +15.27% |
| 1 Year | +11.49% |
| 3 Years (CAGR) | +19.12% |
| 5 Years (CAGR) | +13.79% |
| 10 Years (CAGR) | +16.15% |
| Since Launch | +17.75% |
Returns ≥ 1 year are annualised (CAGR); shorter periods are absolute. Past performance does not guarantee future returns.
FundScore breakdown
Six explainable dimensions. How the score works →
Returns71
Consistency73
Risk-adjusted59
Downside protection86
Cost efficiency80
Portfolio quality50
Why this fund scores well
- ✓ 3Y CAGR: +19.1%
- ✓ 3Y CAGR vs category: +2.4% vs category avg
- ✓ Positive 3Y windows: 98% of rolling 3Y windows positive
- ✓ Alpha vs benchmark: +13.4%
- ✓ Volatility: 15% annualised
Risk metrics
Sharpe ratio
0.74
Sortino ratio
1.06
Volatility
15.42%
Max drawdown
-24.02%
Downside capture
46.40%
SIP return calculator
Back-tested on this fund's actual historical NAVs. Past performance ≠ future returns.
Portfolio & holdings
Top holdings, sector allocation and market-cap split require a paid factsheet feed and are coming soon. Everything above is computed from official daily NAV history and is fully real.